NOVO NORDISK A S - 31 Dec 2025 SCHEDULE 13G/A Report for Innate Pharma SA Ordinary Shares, nominal value (euro) 0.05 per share (including ordinary shares represented by American Depositary Shares)

Filing Manager
NOVO NORDISK A S
Reporting Manager
Novo Nordisk A/S
Security
Innate Pharma SA Ordinary Shares, nominal value (euro) 0.05 per share (including ordinary shares represented by American Depositary Shares)
Shares outstanding
93,782,327 shares
Disclosed Ownership
7,333,778 shares
Ownership
7.8%
Form type
SCHEDULE 13G/A
Filing time
04 Mar 2026, 16:45:11 UTC
Date of event
31 Dec 2025
Previous filing
21 Oct 2025
SEC
View on sec.gov

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Novo Nordisk A/S 7.8% 7,333,778 7,333,778 0 /s/ Karsten Munk Knudsen Karsten Munk Knudsen, Chief Financial Officer